info
Google Groups no longer supports new Usenet posts or subscriptions. Historical content remains viewable.
Dismiss
Crack.crack.gigatribe.3.04.000 | Updated
5 views
Skip to first unread message
Lissette Blaylock
Dec 7, 2023, 9:52:46 AM12/7/23
to
In October 2021, the FATF updated its 2019 Guidance for a Risk-Based Approach to Virtual Assets and Virtual Asset Service Providers (VASPs).RBA for Virtual Assets & Virtual Asset Service ProvidersUpdated Guidance for a Risk-Based Approach for Virtual Assets and Virtual Asset Service Providers
Abstract. Although now over 100 years old, the classification of climate originally formulated by Wladimir Köppen and modified by his collaborators and successors, is still in widespread use. It is widely used in teaching school and undergraduate courses on climate. It is also still in regular use by researchers across a range of disciplines as a basis for climatic regionalisation of variables and for assessing the output of global climate models. Here we have produced a new global map of climate using the Köppen-Geiger system based on a large global data set of long-term monthly precipitation and temperature station time series. Climatic variables used in the Köppen-Geiger system were calculated at each station and interpolated between stations using a two-dimensional (latitude and longitude) thin-plate spline with tension onto a 0.10.1 grid for each continent. We discuss some problems in dealing with sites that are not uniquely classified into one climate type by the Köppen-Geiger system and assess the outcomes on a continent by continent basis. Globally the most common climate type by land area is BWh (14.2%, Hot desert) followed by Aw (11.5%, Tropical savannah). The updated world Köppen-Geiger climate map is freely available electronically in the Supplementary Material Section.
Crack.crack.gigatribe.3.04.000 updated
Download Zip https://urllio.com/2wIVj2
The objective of this paper is to describe the updated methodological guidance for conducting a JBI scoping review, with a focus on new updates to the approach and development of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (the PRISMA-ScR).
Scoping reviews are an increasingly common approach to informing decision-making and research based on the identification and examination of the literature on a given topic or issue. Scoping reviews draw on evidence from any research methodology and may also include evidence from non-research sources, such as policy. In this manner, scoping reviews provide a comprehensive overview to address broader review questions than traditionally more specific systematic reviews of effectiveness or qualitative evidence. The increasing popularity of scoping reviews has been accompanied by the development of a reporting guideline: the PRISMA-ScR. In 2014, the JBI Scoping Review Methodology Group developed guidance for scoping reviews that received minor updates in 2017 and was most recently updated in 2020. The updates reflect ongoing and substantial developments in approaches to scoping review conduct and reporting. As such, the JBI Scoping Review Methodology Group recognized the need to revise the guidance to align with the current state of knowledge and reporting standards in evidence synthesis.
Between 2015 and 2020, the JBI Scoping Review Methodology Group expanded its membership; extensively reviewed the literature; engaged via annual face-to-face meetings, regular teleconferences, and email correspondence; sought advice from methodological experts; facilitated workshops; and presented at scientific conferences. This process led to updated guidance for scoping reviews published in the JBI Manual for Evidence Synthesis. The updated chapter was endorsed by JBI's International Scientific Committee in 2020.
The updated JBI guidance for scoping reviews includes additional guidance on several methodological issues, such as when a scoping review is (or is not) appropriate, and how to extract, analyze, and present results, and provides clarification for implications for practice and research. Furthermore, it is aligned with the PRISMA-ScR to ensure consistent reporting.
This section was originally issued on December 16, 2020, and was updated on October 25, 2021 and July 12, 2022. Note that the Centers for Disease Control and Prevention (CDC) has issued guidance for vaccinated individuals that addresses, among other things, when they need to wear a mask indoors.
There was great interest in the databases of standardized citation metrics across all scientists and scientific disciplines [1], and many scientists urged us to provide updates of the databases. Accordingly, we have provided updated analyses that use citations from Scopus with data freeze as of May 6, 2020, assessing scientists for career-long citation impact up until the end of 2019 (Table-S6-career-2019) and for citation impact during the single calendar year 2019 (Table-S7-singleyr-2019). Updated databases and code are freely available in Mendeley ( ). The original database (version 1) can also be found in , the updated (version 2) can also be found in , and any subsequent updates that might appear in the future will be generally accessible in
A. The HWB Program Portal will be updated regularly with program updates and/or the most up to date information for employers. Please also visit the eMedNY listServ page to subscribe to applicable listServs.
Through the procedures and instructions in this updated memo, OSHA will prioritize its enforcement resources to ensure employers eliminate and control workplace exposures to SARS-CoV-2, the cause of COVID-19, in non-healthcare settings. Additionally, this memorandum provides updated guidance to protect OSHA enforcement personnel.
The Centers for Disease Control and Prevention (CDC) also maintains a website that provides information for employers concerned about COVID-19 infections in the workplace. The CDC has provided specific guidance for businesses and employers at the following CDC webpage, which is updated regularly: Workplaces and Businesses.
The updated criteria take effect on Wednesday 15 June 2022. New applicants are required to adopt these strengthened criteria immediately to join the campaign. Existing Partners and members will need to meet the new criteria by 15th June 2023 at the latest.
Unprecedented measures imposed or recommended by governments, including travel restrictions and curtailment of business operations, have been in effect in most jurisdictions in various forms and stages during most of 2020 due to the COVID-19 pandemic and this situation continues in 2021. This note revisits the guidance issued by the OECD Secretariat on 3 April 2020 on the impact of the COVID-19 pandemic on tax treaties. The guidance represents the Secretariat's views, supported by Working Party 1 (in its Inclusive Framework setting), on the interpretation of the provisions of tax treaties intending to provide more certainty to taxpayers during this exceptional period when those measures were applicable. The guidance reflects the general approach of Working Party 1 and illustrates how some jurisdictions have addressed the impact of COVID-19 on the tax situations of individuals and employers. This updated guidance outlines the application of the existing rules and the OECD Commentary on concerns related to the creation of permanent establishments; the application of "tie-breaker" rules to dual residents; and the tax treaty treatment of income from employment.
Many jurisdictions have issued their own guidance on the treatment of the issues covered in the updated guidance. Links to some of that guidance are included below (noting that this list does not purport to be a complete list of guidance issued). Links available in language of respective jurisdiction.
Update on recommendations on antiretroviral regimens for treating and preventing HIV infection: In 2016, WHO published the consolidated guidelines on the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and recommended tenofovir disoproxil fumarate (TDF) + lamivudine (3TC) (or emtricitabine, FTC) + efavirenz (EFV) 600 mg as the preferred first- line antiretroviral therapy (ART) regimen for adults and adolescents. Since that time, scientific evidence and programmatic experience have accumulated on the use of dolutegravir (DTG) in both first- and second-line ART, including during pregnancy and tuberculosis co-treatment, and for children. In 2018, these guidelines were reviewed to provide updated guidance on preferred option for these populations which now include DTG and raltegravir (RAL), and updated recommendations on using ARV drugs for HIV post-exposure prophylaxis. Annex 3 above links to the ARV dosing guidance for children, adolescents and adults.
On June 15, 2022, EPA issued interim updated drinking water health advisories for perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) that replace those EPA issued in 2016. PFOA and PFOS are members of a chemical group called per- and polyfluoroalkyl substances (PFAS). The updated advisory levels, which are based on new science and consider lifetime exposure, indicate that some negative health effects may occur with concentrations of PFOA or PFOS in water that are near zero. These interim health advisories will remain in place until EPA establishes a National Primary Drinking Water Regulation.
Sea ice data is updated daily, with a one-day lag. The orange line in extent and concentration images (left and middle) and the gray line in the time series (right) indicate 1981 to 2010 average extent for the day shown. The graph also includes lines for selected earlier years, for comparison. Learn about update delays and other problems which occasionally occur in near-real-time data. Read about the data.
In Washington, indoor mask requirements will be lifted as of 11:59 p.m. on March 11. This new date does not change any other aspect of the updated mask requirements Inslee announced last week. Masks will still be required in certain settings including health care, corrections facilities and long-term care facilities. The Washington State Department of Health will be issuing new guidance for K-12 schools next week so schools can prepare to implement updated safety protocols.
eebf2c3492
Abstract. Although now over 100 years old, the classification of climate originally formulated by Wladimir Köppen and modified by his collaborators and successors, is still in widespread use. It is widely used in teaching school and undergraduate courses on climate. It is also still in regular use by researchers across a range of disciplines as a basis for climatic regionalisation of variables and for assessing the output of global climate models. Here we have produced a new global map of climate using the Köppen-Geiger system based on a large global data set of long-term monthly precipitation and temperature station time series. Climatic variables used in the Köppen-Geiger system were calculated at each station and interpolated between stations using a two-dimensional (latitude and longitude) thin-plate spline with tension onto a 0.10.1 grid for each continent. We discuss some problems in dealing with sites that are not uniquely classified into one climate type by the Köppen-Geiger system and assess the outcomes on a continent by continent basis. Globally the most common climate type by land area is BWh (14.2%, Hot desert) followed by Aw (11.5%, Tropical savannah). The updated world Köppen-Geiger climate map is freely available electronically in the Supplementary Material Section.
Crack.crack.gigatribe.3.04.000 updated
Download Zip https://urllio.com/2wIVj2
The objective of this paper is to describe the updated methodological guidance for conducting a JBI scoping review, with a focus on new updates to the approach and development of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (the PRISMA-ScR).
Scoping reviews are an increasingly common approach to informing decision-making and research based on the identification and examination of the literature on a given topic or issue. Scoping reviews draw on evidence from any research methodology and may also include evidence from non-research sources, such as policy. In this manner, scoping reviews provide a comprehensive overview to address broader review questions than traditionally more specific systematic reviews of effectiveness or qualitative evidence. The increasing popularity of scoping reviews has been accompanied by the development of a reporting guideline: the PRISMA-ScR. In 2014, the JBI Scoping Review Methodology Group developed guidance for scoping reviews that received minor updates in 2017 and was most recently updated in 2020. The updates reflect ongoing and substantial developments in approaches to scoping review conduct and reporting. As such, the JBI Scoping Review Methodology Group recognized the need to revise the guidance to align with the current state of knowledge and reporting standards in evidence synthesis.
Between 2015 and 2020, the JBI Scoping Review Methodology Group expanded its membership; extensively reviewed the literature; engaged via annual face-to-face meetings, regular teleconferences, and email correspondence; sought advice from methodological experts; facilitated workshops; and presented at scientific conferences. This process led to updated guidance for scoping reviews published in the JBI Manual for Evidence Synthesis. The updated chapter was endorsed by JBI's International Scientific Committee in 2020.
The updated JBI guidance for scoping reviews includes additional guidance on several methodological issues, such as when a scoping review is (or is not) appropriate, and how to extract, analyze, and present results, and provides clarification for implications for practice and research. Furthermore, it is aligned with the PRISMA-ScR to ensure consistent reporting.
This section was originally issued on December 16, 2020, and was updated on October 25, 2021 and July 12, 2022. Note that the Centers for Disease Control and Prevention (CDC) has issued guidance for vaccinated individuals that addresses, among other things, when they need to wear a mask indoors.
There was great interest in the databases of standardized citation metrics across all scientists and scientific disciplines [1], and many scientists urged us to provide updates of the databases. Accordingly, we have provided updated analyses that use citations from Scopus with data freeze as of May 6, 2020, assessing scientists for career-long citation impact up until the end of 2019 (Table-S6-career-2019) and for citation impact during the single calendar year 2019 (Table-S7-singleyr-2019). Updated databases and code are freely available in Mendeley ( ). The original database (version 1) can also be found in , the updated (version 2) can also be found in , and any subsequent updates that might appear in the future will be generally accessible in
A. The HWB Program Portal will be updated regularly with program updates and/or the most up to date information for employers. Please also visit the eMedNY listServ page to subscribe to applicable listServs.
Through the procedures and instructions in this updated memo, OSHA will prioritize its enforcement resources to ensure employers eliminate and control workplace exposures to SARS-CoV-2, the cause of COVID-19, in non-healthcare settings. Additionally, this memorandum provides updated guidance to protect OSHA enforcement personnel.
The Centers for Disease Control and Prevention (CDC) also maintains a website that provides information for employers concerned about COVID-19 infections in the workplace. The CDC has provided specific guidance for businesses and employers at the following CDC webpage, which is updated regularly: Workplaces and Businesses.
The updated criteria take effect on Wednesday 15 June 2022. New applicants are required to adopt these strengthened criteria immediately to join the campaign. Existing Partners and members will need to meet the new criteria by 15th June 2023 at the latest.
Unprecedented measures imposed or recommended by governments, including travel restrictions and curtailment of business operations, have been in effect in most jurisdictions in various forms and stages during most of 2020 due to the COVID-19 pandemic and this situation continues in 2021. This note revisits the guidance issued by the OECD Secretariat on 3 April 2020 on the impact of the COVID-19 pandemic on tax treaties. The guidance represents the Secretariat's views, supported by Working Party 1 (in its Inclusive Framework setting), on the interpretation of the provisions of tax treaties intending to provide more certainty to taxpayers during this exceptional period when those measures were applicable. The guidance reflects the general approach of Working Party 1 and illustrates how some jurisdictions have addressed the impact of COVID-19 on the tax situations of individuals and employers. This updated guidance outlines the application of the existing rules and the OECD Commentary on concerns related to the creation of permanent establishments; the application of "tie-breaker" rules to dual residents; and the tax treaty treatment of income from employment.
Many jurisdictions have issued their own guidance on the treatment of the issues covered in the updated guidance. Links to some of that guidance are included below (noting that this list does not purport to be a complete list of guidance issued). Links available in language of respective jurisdiction.
Update on recommendations on antiretroviral regimens for treating and preventing HIV infection: In 2016, WHO published the consolidated guidelines on the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and recommended tenofovir disoproxil fumarate (TDF) + lamivudine (3TC) (or emtricitabine, FTC) + efavirenz (EFV) 600 mg as the preferred first- line antiretroviral therapy (ART) regimen for adults and adolescents. Since that time, scientific evidence and programmatic experience have accumulated on the use of dolutegravir (DTG) in both first- and second-line ART, including during pregnancy and tuberculosis co-treatment, and for children. In 2018, these guidelines were reviewed to provide updated guidance on preferred option for these populations which now include DTG and raltegravir (RAL), and updated recommendations on using ARV drugs for HIV post-exposure prophylaxis. Annex 3 above links to the ARV dosing guidance for children, adolescents and adults.
On June 15, 2022, EPA issued interim updated drinking water health advisories for perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) that replace those EPA issued in 2016. PFOA and PFOS are members of a chemical group called per- and polyfluoroalkyl substances (PFAS). The updated advisory levels, which are based on new science and consider lifetime exposure, indicate that some negative health effects may occur with concentrations of PFOA or PFOS in water that are near zero. These interim health advisories will remain in place until EPA establishes a National Primary Drinking Water Regulation.
Sea ice data is updated daily, with a one-day lag. The orange line in extent and concentration images (left and middle) and the gray line in the time series (right) indicate 1981 to 2010 average extent for the day shown. The graph also includes lines for selected earlier years, for comparison. Learn about update delays and other problems which occasionally occur in near-real-time data. Read about the data.
In Washington, indoor mask requirements will be lifted as of 11:59 p.m. on March 11. This new date does not change any other aspect of the updated mask requirements Inslee announced last week. Masks will still be required in certain settings including health care, corrections facilities and long-term care facilities. The Washington State Department of Health will be issuing new guidance for K-12 schools next week so schools can prepare to implement updated safety protocols.
eebf2c3492
0 new messages